| Net sales | $2.3M+1106.2% | $194K |
| Cost of sales | $91.5M+204.9% | $30.0M |
| Selling, general and administrative expenses | $54.4M-60.6% | $138.3M |
| Research and development expenses | $33.3M-69.1% | $107.8M |
| Reorganization items | $31.2M | — |
| Impairment of property plant & equipment and intangibles | $140.7M+26.3% | $111.4M |
| Total operating expenses | $259.7M-27.4% | $357.5M |
| Loss from operations | -$348.9M+9.9% | -$387.3M |
| (Loss) gain on sale of assets | -$916K-100.9% | $100.9M |
| Other income | $123K-84.4% | $788K |
| Investment and interest income | $6.6M+106.6% | $3.2M |
| Loss before income taxes | -$343.1M-21.5% | -$282.4M |
| Income tax expense | $0 | $0 |
| Net loss | -$343.1M-21.5% | -$282.4M |
| Less preferred stock dividend | $2.5M+855.6% | $261K |
| Net loss attributable to common shareholders | -$345.6M-22.3% | -$282.7M |
| Basic (in dollars per share) | -$22K-6.6% | -$20K |
| Diluted (in dollars per share) | -$22K-6.6% | -$20K |
| Basic (in shares) | $15.9M+14.6% | $13.9M |
| Diluted (in shares) | $15.9M+14.6% | $13.9M |
